148 related articles for article (PubMed ID: 18062778)
1. Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.
Iida M; Matsuda M; Komatani H
Biochem J; 2008 Apr; 411(1):27-32. PubMed ID: 18062778
[TBL] [Abstract][Full Text] [Related]
2. Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIalpha in cell cycle progression.
Li H; Wang Y; Liu X
J Biol Chem; 2008 Mar; 283(10):6209-21. PubMed ID: 18171681
[TBL] [Abstract][Full Text] [Related]
3. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
4. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
Ando K; Ozaki T; Hirota T; Nakagawara A
PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
[TBL] [Abstract][Full Text] [Related]
5. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210.
Wu B; Jiang P; Mu Y; Wilmouth RC
Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues.
Winkles JA; Alberts GF
Oncogene; 2005 Jan; 24(2):260-6. PubMed ID: 15640841
[TBL] [Abstract][Full Text] [Related]
7. Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.
Reindl W; Gräber M; Strebhardt K; Berg T
Anal Biochem; 2009 Dec; 395(2):189-94. PubMed ID: 19716361
[TBL] [Abstract][Full Text] [Related]
8. TTDN1 is a Plk1-interacting protein involved in maintenance of cell cycle integrity.
Zhang Y; Tian Y; Chen Q; Chen D; Zhai Z; Shu HB
Cell Mol Life Sci; 2007 Mar; 64(5):632-40. PubMed ID: 17310276
[TBL] [Abstract][Full Text] [Related]
9. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation.
Ismail IA; Kang KS; Lee HA; Kim JW; Sohn YK
Eur J Pharmacol; 2007 Dec; 575(1-3):12-20. PubMed ID: 17706963
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity.
Johnson EF; Stewart KD; Woods KW; Giranda VL; Luo Y
Biochemistry; 2007 Aug; 46(33):9551-63. PubMed ID: 17655330
[TBL] [Abstract][Full Text] [Related]
11. Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide-induced mitotically arrested cells.
Chen YJ; Lin YP; Chow LP; Lee TC
Proteomics; 2011 Nov; 11(22):4331-45. PubMed ID: 21887822
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD.
Jang MS; Lee SJ; Kim CJ; Lee CW; Kim E
Oncogene; 2011 Jan; 30(4):471-81. PubMed ID: 20890306
[TBL] [Abstract][Full Text] [Related]
13. The highly basic ribosomal protein L41 interacts with the beta subunit of protein kinase CKII and stimulates phosphorylation of DNA topoisomerase IIalpha by CKII.
Lee JH; Kim JM; Kim MS; Lee YT; Marshak DR; Bae YS
Biochem Biophys Res Commun; 1997 Sep; 238(2):462-7. PubMed ID: 9299532
[TBL] [Abstract][Full Text] [Related]
14. Threonine 1342 in human topoisomerase IIalpha is phosphorylated throughout the cell cycle.
Ishida R; Iwai M; Marsh KL; Austin CA; Yano T; Shibata M; Nozaki N; Hara A
J Biol Chem; 1996 Nov; 271(47):30077-82. PubMed ID: 8939955
[TBL] [Abstract][Full Text] [Related]
15. A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2.
Kim HL; Jeon KH; Jun KY; Choi Y; Kim DK; Na Y; Kwon Y
Cancer Lett; 2012 Dec; 325(1):72-9. PubMed ID: 22732416
[TBL] [Abstract][Full Text] [Related]
16. Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
Komatsu S; Takenobu H; Ozaki T; Ando K; Koida N; Suenaga Y; Ichikawa T; Hishiki T; Chiba T; Iwama A; Yoshida H; Ohnuma N; Nakagawara A; Kamijo T
Oncogene; 2009 Oct; 28(41):3631-41. PubMed ID: 19668228
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Chauhan FA; Kashyap S
Clin Exp Ophthalmol; 2015 Aug; 43(6):550-7. PubMed ID: 25754767
[TBL] [Abstract][Full Text] [Related]
18. Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.
Baxter M; Chapagai D; Craig S; Hurtado C; Varghese J; Nurmemmedov E; Wyatt MD; McInnes C
ChemMedChem; 2020 Jun; 15(12):1058-1066. PubMed ID: 32232973
[TBL] [Abstract][Full Text] [Related]
19. Plk1-mediated mitotic phosphorylation of PinX1 regulates its stability.
Wang C; Yu J; Yuan K; Lan J; Jin C; Huang H
Eur J Cell Biol; 2010 Oct; 89(10):748-56. PubMed ID: 20573420
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis.
Yamaguchi T; Goto H; Yokoyama T; Silljé H; Hanisch A; Uldschmid A; Takai Y; Oguri T; Nigg EA; Inagaki M
J Cell Biol; 2005 Nov; 171(3):431-6. PubMed ID: 16260496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
